DK1668003T3 - Benzisoxazoler - Google Patents

Benzisoxazoler

Info

Publication number
DK1668003T3
DK1668003T3 DK04787069T DK04787069T DK1668003T3 DK 1668003 T3 DK1668003 T3 DK 1668003T3 DK 04787069 T DK04787069 T DK 04787069T DK 04787069 T DK04787069 T DK 04787069T DK 1668003 T3 DK1668003 T3 DK 1668003T3
Authority
DK
Denmark
Prior art keywords
benzisoxazoles
pharmaceuticals
reversible
preparation
fatty acid
Prior art date
Application number
DK04787069T
Other languages
Danish (da)
English (en)
Inventor
Joachim Nozulak
Hans O Kalkman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1668003T3 publication Critical patent/DK1668003T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK04787069T 2003-10-01 2004-09-30 Benzisoxazoler DK1668003T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0322994.5A GB0322994D0 (en) 2003-10-01 2003-10-01 Organic compounds
PCT/EP2004/010938 WO2005030763A1 (en) 2003-10-01 2004-09-30 Benzisoxazoles

Publications (1)

Publication Number Publication Date
DK1668003T3 true DK1668003T3 (da) 2008-03-03

Family

ID=29415309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04787069T DK1668003T3 (da) 2003-10-01 2004-09-30 Benzisoxazoler

Country Status (13)

Country Link
US (7) US20070197595A1 (el)
EP (1) EP1668003B1 (el)
JP (2) JP2007507455A (el)
AT (1) ATE378331T1 (el)
CY (1) CY1107277T1 (el)
DE (1) DE602004010161T2 (el)
DK (1) DK1668003T3 (el)
ES (1) ES2297493T3 (el)
GB (1) GB0322994D0 (el)
PL (1) PL1668003T3 (el)
PT (1) PT1668003E (el)
SI (1) SI1668003T1 (el)
WO (1) WO2005030763A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds
WO2012032532A1 (en) * 2010-09-07 2012-03-15 Symed Labs Limited "processes for the preparation of 4'-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]propoxy]-3'-methoxyacetophenone and intermediates thereof"
BR112014022687A8 (pt) * 2012-03-14 2021-07-06 Vanda Pharmaceuticals Inc uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst Roussel Pharma N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
IL119095A (en) * 1996-08-19 2000-06-01 Mul T Lock Technologies Ltd Lock housing
US6225321B1 (en) * 1997-06-05 2001-05-01 Oliver Yoa-Pu Hu Long analgesic acting nalbuphine polyester derivative and method of use
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
JP4634694B2 (ja) * 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
JP2005504783A (ja) * 2001-08-31 2005-02-17 ノバルティス アクチエンゲゼルシャフト イロペリドン代謝産物の光学異性体
WO2004010932A2 (en) * 2002-07-30 2004-02-05 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ATE378331T1 (de) 2007-11-15
DE602004010161D1 (de) 2007-12-27
US20200131166A1 (en) 2020-04-30
SI1668003T1 (sl) 2008-04-30
WO2005030763A1 (en) 2005-04-07
PT1668003E (pt) 2007-12-31
PL1668003T3 (pl) 2008-05-30
US20070197595A1 (en) 2007-08-23
JP5794667B2 (ja) 2015-10-14
US20170129878A1 (en) 2017-05-11
JP2007507455A (ja) 2007-03-29
GB0322994D0 (en) 2003-11-05
US20190055228A1 (en) 2019-02-21
JP2011157377A (ja) 2011-08-18
ES2297493T3 (es) 2008-05-01
CY1107277T1 (el) 2012-11-21
DE602004010161T2 (de) 2008-10-30
US20110172272A1 (en) 2011-07-14
US20180118729A1 (en) 2018-05-03
EP1668003A1 (en) 2006-06-14
EP1668003B1 (en) 2007-11-14
US20190276444A1 (en) 2019-09-12

Similar Documents

Publication Publication Date Title
EA201070698A1 (ru) Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
MX2007014892A (es) Formas polimorficas del ester etilico del acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}- 1-metil-h-bencimidazol-5-carbonil)-piridin-2-il--amino]propionico .
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
NO20073601L (no) Immunresponsmodifikator-skumformuleringer
TW200716568A (en) 1H-quinazoline-2,4-diones
NO20074895L (no) Isoksazolin derivat og ny fremgangsmate for fremstilling derav
HN2003000044A (es) Esteres hidroxamato del acido n - (4-fenil sustituido)-antranilico.
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
SE0302546D0 (sv) New compounds
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
NO20084478L (no) Konjugerte lipidderivater
SE0300091D0 (sv) Novel compounds
MX2011013130A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
CY1107277T1 (el) Βενζισοξαζολες
NO20073046L (no) Utvalgte benzofuranderivater
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
FR2915993B1 (fr) Nouveaux ligands agonistes des recepteurs pars, utilisation en medecine humaine ainsi qu'en cosmetique.
RU2011143735A (ru) Средство для отбеливания кожи и косметический способ отбеливания кожи
GEP20125563B (en) 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same
ATE546451T1 (de) Cyclopropancarbonsäureester von acyclovir